tiprankstipranks
Standard BioTools (LAB)
NASDAQ:LAB

Standard BioTools (LAB) Financial Statements

424 Followers

Standard BioTools Financial Overview

Standard BioTools's market cap is currently ―. The company's EPS TTM is $-0.995; its P/E ratio is -2.20; Standard BioTools is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 45.54M$ 28.19M$ 25.37M$ 27.67M$ 25.12M
Gross Profit$ 24.19M$ 10.78M$ 11.15M$ 13.60M$ 12.12M
EBIT$ -38.73M$ -18.84M$ -19.72M$ -15.61M$ -15.46M
EBITDA$ -33.54M$ -14.93M$ -16.74M$ -12.60M$ -12.46M
Net Income Common Stockholders$ -78.17M$ -19.78M$ -21.00M$ -17.04M$ -16.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 462.28M$ 114.89M$ 128.85M$ 142.30M$ 154.54M
Total Assets$ 777.67M$ 323.07M$ 339.29M$ 355.83M$ 371.65M
Total Debt$ 91.90M$ 98.21M$ 99.72M$ 101.39M$ 101.98M
Net Debt$ -370.38M$ -16.68M$ -29.13M$ -40.92M$ -52.55M
Total Liabilities$ 200.35M$ 159.87M$ 159.75M$ 157.96M$ 157.55M
Stockholders Equity$ 577.32M$ -148.05M$ -131.72M$ -113.39M$ -97.15M
Cash Flow-
Free Cash Flow$ -63.26M$ -14.14M$ -12.32M$ -10.17M$ -9.49M
Operating Cash Flow$ -62.48M$ -14.06M$ -11.41M$ -9.33M$ -8.48M
Investing Cash Flow$ 318.07M$ -13.12M$ -49.93M$ 40.13M$ 43.15M
Financing Cash Flow$ -19.73M$ -1.00M$ -1.16M$ -2.08M$ -2.59M
Currency in USD

Standard BioTools Earnings and Revenue History

Standard BioTools Debt to Assets

Standard BioTools Cash Flow

Standard BioTools Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis